The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA.

Trial Profile

The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2016

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PICCOLA
  • Most Recent Events

    • 24 Mar 2012 This trial is recruiting in United Kingdom.
    • 24 Mar 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2007-001222-27).
    • 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top